← Browse by Condition
Medical Condition

egfr l861q

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06517953 Phase 2
Recruiting

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

Enrollment
23 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →